MRNA vs REPX · rev $145.0M vs P/E 12, rev $279.7M
Moderna Inc (MRNA) versus Riley Exploration Permian Inc (REPX) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Riley Exploration Permian Inc (REPX) is a oil & gas e&p company listed on AMEX.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported REPX revenue for 2026-06-30 was $279.7M. Net income was $16.9M. REPX currently screens at market cap $727.0M and trailing P/E 11.7.
MRNA currently screens at market cap $24.52B. REPX currently screens at market cap $727.0M and trailing P/E 11.7.
Not investment advice. Open the MRNA and REPX stock pages for the full models.
Not investment advice.